Featured Article

Dyslipidemia and Atherosclerosis Clinical Practice Guidelines

Dyslipidemia and Atherosclerosis Clinical Practice Guidelines

New guidelines for dyslipidemia management and atherosclerosis prevention include a wider range of disease stages and more aggressive intervention.

Latest Features

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.

Statins Limit Vaccine Efficacy of Influenza Strain

Statins Limit Vaccine Efficacy of Influenza Strain

Statin use modified vaccine effectiveness and influenza risk for A(H3N2) infection but not for A(H1N1).

Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C

Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C

Vitamin D may influence cardiovascular disease risk via its effect on lipid levels.

Considering Cardiovascular Risks of Antidiabetic Drugs

Considering Cardiovascular Risks of Antidiabetic Drugs

A review of current antidiabetic drug treatments available and their individual cardiovascular risk profiles.

PCSK9 Inhibitors: Breakthrough in LDL-C Reduction, But Comes at a Cost

PCSK9 Inhibitors: Breakthrough in LDL-C Reduction, But Comes at a Cost

PCSK9 inhibitors may offer hope to patients with familial hypercholesterolemia who cannot tolerate or achieve goal LDL-C levels with statins.

LATEST NEWS

Evolocumab Added to Statin Therapy Does Not Affect Cognition

Evolocumab Added to Statin Therapy Does Not Affect Cognition

There is no significant difference in cognitive function for patients treated with evolocumab or placebo added to statin therapy.

Marked Variations in Statin Use in Nursing Home Residents

Marked Variations in Statin Use in Nursing Home Residents

Statin prescribing trends vary among nursing home residents with significant variation of prescribing across physicians.

Multiple Cardiometabolic Comorbidities Prevalent in Psoriasis

Multiple Cardiometabolic Comorbidities Prevalent in Psoriasis

Patients with psoriasis have high rates of cardiometabolic comorbidities.

Noncalcified, High-Risk Coronary Plaque Burden Increased With Psoriasis

Noncalcified, High-Risk Coronary Plaque Burden Increased With Psoriasis

Individuals with psoriasis have a greater risk for noncalcified coronary plaque burden compared with healthy individuals and patients with hyperlipidemia.

FDA Approves Pitavastatin as Adjunctive Therapy for Hyperlipidemia or Mixed Dyslipidemia

FDA Approves Pitavastatin as Adjunctive Therapy for Hyperlipidemia or Mixed Dyslipidemia

The FDA has approved Zypitamag for the treatment of patients with primary hyperlipidemia or mixed dyslipidemia.

Statins Reduce Cardiovascular Events, Death Even With Adverse Reactions

Statins Reduce Cardiovascular Events, Death Even With Adverse Reactions

Statin use after an adverse reaction is associated with lower incidences of cardiovascular events and death.

Glycemic Control Improves With Hepatitis C Treatment

Glycemic Control Improves With Hepatitis C Treatment

Direct-acting antiviral treatment for hepatitis C virus is linked to improved glycemic control in patients with type 2 diabetes.

CVD Risk in Juvenile Idiopathic Arthritis May Be Linked to Vitamin D Levels

CVD Risk in Juvenile Idiopathic Arthritis May Be Linked to Vitamin D Levels

Serum Vitamin D levels are related to cholesterol levels and other risk factors for cardiovascular disease in patients with juvenile idiopathic arthritis.

PCSK9 Inhibitor Trends in Type 1 Diabetes

PCSK9 Inhibitor Trends in Type 1 Diabetes

PCSK9 had a significant correlation with hemoglobin A1c, triglycerides, total cholesterol, LDL cholesterol, and apolipoprotein B in patients with type 1 diabetes.

Total Cholesterol, Low-Density Lipoprotein Cholesterol Levels Affect Parkinson's Risk

Total Cholesterol, Low-Density Lipoprotein Cholesterol Levels Affect Parkinson's Risk

A decreased risk in Parkinson's disease has been associated with total serum cholesterol and low-density lipoprotein cholesterol in men not on statin therapy.

Sign Up for Free e-Newsletters